Smacムービングコイルアクチュエーターズ、ip規格製品を発表
December 27, 2017 08:00 ET
|
SMAC Corporation
カリフォルニア州カールスバッド発, Dec. 27, 2017 (GLOBE NEWSWIRE) -- SMACムービングコイルアクチュエーターズ (SMAC Moving Coil Actuators)...
BioEnterprise to Lead Strategy for the Global Center for Health Innovation
October 16, 2017 09:47 ET
|
BioEnterprise, Inc.
CLEVELAND, Oct. 16, 2017 (GLOBE NEWSWIRE) -- BioEnterprise, a leader in growing the Northeast Ohio biomedical industry, announced today that it has reached an agreement with the Cuyahoga County...
Midwest Healthcare Startups Raise $967 Million in First Half of 2017
August 28, 2017 12:20 ET
|
BioEnterprise, Inc.
CLEVELAND , Aug. 28, 2017 (GLOBE NEWSWIRE) -- Midwest healthcare companies attracted $967 million in new equity investments in the first-half of 2017, according to the BioEnterprise Midwest...
Kraig Biocraft Laboratories delivers first fiber sample to medical application firm for performance and suitability testing
August 22, 2017 06:57 ET
|
Kraig Biocraft Laboratories, Inc.
ANN ARBOR, Mich., Aug. 22, 2017 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that the Company...
Link Revised - Dr. Schwartz CEO of SKLN and Dr. Garvin with CytoBioscience Discuss Positive Results of a Merger in Progress with Their Two Companies
August 16, 2017 10:57 ET
|
Skyline Medical Inc.
Eagan, MN , Aug. 16, 2017 (GLOBE NEWSWIRE) -- Link Revised - Dr. Schwartz CEO of SKLN and Dr. Garvin with CytoBioscience Discuss Positive Results of a Merger in Progress with Their Two Companies ...
Dr. Schwartz CEO of SKLN and Dr. Garvin with CytoBioscience Discuss Positive Results of a Merger in Progress with Their Two Companies
August 16, 2017 09:00 ET
|
Skyline Medical Inc.
Eagan, MN , Aug. 16, 2017 (GLOBE NEWSWIRE) -- Dr. Schwartz CEO of SKLN and Dr. Garvin with CytoBioscience Discuss Positive Results of a Merger in Progress with Their Two Companies Eagan, MN (UPTICK...
PreveCeutical™ Medical Inc. Announces Preliminary Results from Phase One of its Venom Re-Engineering Project
August 11, 2017 03:05 ET
|
PreveCeutical Medical Inc
VANCOUVER, British Columbia, Aug. 11, 2017 (GLOBE NEWSWIRE) -- PreveCeutical™ Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) (FSE:18H) announces encouraging results from the Research and...
PreveCeutical™ Medical Inc. Begins Trading on the Frankfurt Stock Exchange
August 01, 2017 08:30 ET
|
PreveCeutical Medical Inc
VANCOUVER, British Columbia, Aug. 01, 2017 (GLOBE NEWSWIRE) -- PreveCeutical™ Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) announces the listing of its common shares for trading on the...
PreveCeutical™ Medical Inc. Launches Phase One of Venom Re-Engineering Project
July 25, 2017 08:30 ET
|
PreveCeutical Medical Inc
VANCOUVER, British Columbia, July 25, 2017 (GLOBE NEWSWIRE) -- PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) announces the launch of the Company’s multi-faceted Research...
Chart to Acquire Hudson Products
June 30, 2017 16:05 ET
|
Chart Industries, Inc.
Enhances Chart’s core platformAdds highly complementary Fans businessStrengthens aftermarket presenceConsistent with Chart’s strategic growth initiativesSignificant cost synergiesEfficient use of...